 Joanna Etra
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascularized Composite Allotransplantation | 10 | 2021 | 30 | 2.760 |
Why?
| | Graft Rejection | 8 | 2021 | 540 | 1.890 |
Why?
| | Skin Transplantation | 3 | 2021 | 85 | 0.750 |
Why?
| | Hindlimb | 2 | 2019 | 131 | 0.700 |
Why?
| | Wounds, Stab | 1 | 2021 | 12 | 0.670 |
Why?
| | Isoantibodies | 2 | 2018 | 57 | 0.670 |
Why?
| | Myocutaneous Flap | 1 | 2020 | 8 | 0.650 |
Why?
| | Superficial Back Muscles | 1 | 2020 | 16 | 0.640 |
Why?
| | Amputation, Traumatic | 1 | 2020 | 21 | 0.620 |
Why?
| | Blast Injuries | 1 | 2020 | 63 | 0.610 |
Why?
| | Arm | 1 | 2020 | 110 | 0.600 |
Why?
| | Mammaplasty | 2 | 2020 | 104 | 0.600 |
Why?
| | Immune Tolerance | 2 | 2019 | 379 | 0.580 |
Why?
| | Vascular Grafting | 1 | 2019 | 15 | 0.580 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2019 | 19 | 0.580 |
Why?
| | Femoral Vein | 1 | 2019 | 38 | 0.570 |
Why?
| | Bilirubin | 2 | 2016 | 97 | 0.530 |
Why?
| | Skin | 2 | 2020 | 758 | 0.530 |
Why?
| | Violence | 1 | 2021 | 281 | 0.520 |
Why?
| | Wounds, Gunshot | 1 | 2021 | 258 | 0.510 |
Why?
| | Anterior Compartment Syndrome | 1 | 2016 | 4 | 0.480 |
Why?
| | Pancreas Transplantation | 3 | 2020 | 69 | 0.460 |
Why?
| | Hepatectomy | 2 | 2016 | 273 | 0.460 |
Why?
| | Renal Dialysis | 1 | 2019 | 462 | 0.430 |
Why?
| | Hepatic Insufficiency | 1 | 2014 | 3 | 0.430 |
Why?
| | Diagnostic Errors | 1 | 2016 | 175 | 0.420 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 269 | 0.400 |
Why?
| | Graft Survival | 6 | 2020 | 526 | 0.380 |
Why?
| | Swine | 4 | 2023 | 833 | 0.330 |
Why?
| | Kidney Transplantation | 3 | 2020 | 704 | 0.290 |
Why?
| | Myocardial Infarction | 1 | 2016 | 1209 | 0.270 |
Why?
| | Organ Preservation | 2 | 2019 | 130 | 0.270 |
Why?
| | Microsurgery | 2 | 2019 | 72 | 0.240 |
Why?
| | Organ Transplantation | 2 | 2019 | 248 | 0.240 |
Why?
| | Time Factors | 5 | 2019 | 7183 | 0.200 |
Why?
| | Central Venous Catheters | 1 | 2023 | 53 | 0.180 |
Why?
| | Tissue Donors | 3 | 2020 | 424 | 0.180 |
Why?
| | Databases, Factual | 2 | 2021 | 1486 | 0.180 |
Why?
| | Upper Extremity | 2 | 2021 | 112 | 0.170 |
Why?
| | Retrospective Studies | 9 | 2021 | 17101 | 0.170 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 123 | 0.170 |
Why?
| | Baltimore | 1 | 2021 | 71 | 0.170 |
Why?
| | Immunosuppressive Agents | 3 | 2020 | 847 | 0.160 |
Why?
| | Animals | 12 | 2023 | 38109 | 0.160 |
Why?
| | Perfusion | 2 | 2019 | 250 | 0.160 |
Why?
| | Transplantation, Autologous | 2 | 2019 | 292 | 0.160 |
Why?
| | Abdominal Wall | 1 | 2019 | 27 | 0.150 |
Why?
| | Scrotum | 1 | 2019 | 24 | 0.150 |
Why?
| | Chimerism | 1 | 2019 | 35 | 0.150 |
Why?
| | Transplantation Chimera | 1 | 2019 | 56 | 0.150 |
Why?
| | Transplantation Tolerance | 1 | 2019 | 37 | 0.150 |
Why?
| | Swine, Miniature | 1 | 2019 | 89 | 0.150 |
Why?
| | Transplantation | 1 | 2019 | 33 | 0.150 |
Why?
| | Postoperative Complications | 4 | 2019 | 2920 | 0.150 |
Why?
| | Cryobiology | 1 | 2018 | 1 | 0.140 |
Why?
| | Tissue and Organ Procurement | 2 | 2020 | 346 | 0.140 |
Why?
| | Regenerative Medicine | 1 | 2019 | 50 | 0.140 |
Why?
| | Perioperative Period | 1 | 2019 | 71 | 0.140 |
Why?
| | Vascular Patency | 1 | 2019 | 121 | 0.140 |
Why?
| | Follow-Up Studies | 5 | 2019 | 5417 | 0.140 |
Why?
| | Postoperative Care | 1 | 2020 | 288 | 0.140 |
Why?
| | Composite Tissue Allografts | 1 | 2018 | 8 | 0.140 |
Why?
| | Drug Prescriptions | 1 | 2020 | 285 | 0.140 |
Why?
| | Amputees | 1 | 2019 | 98 | 0.140 |
Why?
| | Male | 14 | 2021 | 72406 | 0.140 |
Why?
| | Georgia | 2 | 2016 | 83 | 0.140 |
Why?
| | Humans | 21 | 2021 | 144957 | 0.130 |
Why?
| | Intraoperative Complications | 1 | 2019 | 156 | 0.130 |
Why?
| | Desensitization, Immunologic | 1 | 2018 | 89 | 0.130 |
Why?
| | Arteries | 1 | 2019 | 259 | 0.130 |
Why?
| | Hyperbilirubinemia | 1 | 2016 | 11 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2019 | 11695 | 0.120 |
Why?
| | Biopsy | 1 | 2019 | 1077 | 0.120 |
Why?
| | Artificial Limbs | 1 | 2019 | 203 | 0.120 |
Why?
| | Reoperation | 1 | 2019 | 631 | 0.120 |
Why?
| | Implant Capsular Contracture | 1 | 2015 | 4 | 0.120 |
Why?
| | Heart Arrest | 1 | 2020 | 407 | 0.110 |
Why?
| | Female | 12 | 2021 | 78376 | 0.110 |
Why?
| | Tissue Engineering | 1 | 2019 | 442 | 0.110 |
Why?
| | Lower Extremity | 1 | 2019 | 438 | 0.110 |
Why?
| | Feasibility Studies | 1 | 2019 | 1095 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1540 | 0.100 |
Why?
| | Video-Assisted Surgery | 1 | 2013 | 3 | 0.100 |
Why?
| | Liver Regeneration | 1 | 2014 | 46 | 0.100 |
Why?
| | Mammography | 1 | 2015 | 166 | 0.100 |
Why?
| | Incidence | 1 | 2021 | 2883 | 0.100 |
Why?
| | Lip | 1 | 2013 | 22 | 0.100 |
Why?
| | Young Adult | 4 | 2021 | 14126 | 0.100 |
Why?
| | Facial Injuries | 1 | 2013 | 25 | 0.100 |
Why?
| | Bites and Stings | 1 | 2013 | 30 | 0.100 |
Why?
| | Mouth Mucosa | 1 | 2013 | 88 | 0.100 |
Why?
| | Hospital Costs | 1 | 2014 | 124 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 529 | 0.100 |
Why?
| | Orthopedic Procedures | 1 | 2016 | 243 | 0.100 |
Why?
| | Early Diagnosis | 1 | 2014 | 249 | 0.100 |
Why?
| | Middle Aged | 6 | 2019 | 35928 | 0.090 |
Why?
| | Lymph Node Excision | 1 | 2013 | 173 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1563 | 0.090 |
Why?
| | Surgical Flaps | 1 | 2013 | 142 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3415 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 676 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4569 | 0.090 |
Why?
| | Adult | 8 | 2021 | 40506 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1143 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1358 | 0.080 |
Why?
| | Pancreatectomy | 1 | 2014 | 285 | 0.080 |
Why?
| | Up-Regulation | 1 | 2014 | 852 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2925 | 0.080 |
Why?
| | Adipose Tissue | 1 | 2015 | 653 | 0.080 |
Why?
| | Aged | 5 | 2019 | 25947 | 0.080 |
Why?
| | Penis | 2 | 2020 | 32 | 0.080 |
Why?
| | Laparoscopy | 1 | 2014 | 475 | 0.080 |
Why?
| | Transplantation, Isogeneic | 2 | 2019 | 17 | 0.070 |
Why?
| | Rats, Inbred Lew | 2 | 2019 | 103 | 0.070 |
Why?
| | Risk Assessment | 2 | 2019 | 3676 | 0.070 |
Why?
| | Transplantation, Homologous | 2 | 2020 | 415 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 2118 | 0.070 |
Why?
| | Tacrolimus | 2 | 2020 | 196 | 0.070 |
Why?
| | Veterans | 1 | 2020 | 1603 | 0.070 |
Why?
| | Aged, 80 and over | 3 | 2016 | 8279 | 0.070 |
Why?
| | Pancreas | 2 | 2020 | 342 | 0.060 |
Why?
| | Models, Animal | 2 | 2019 | 392 | 0.060 |
Why?
| | Melanoma | 1 | 2013 | 761 | 0.060 |
Why?
| | Quality of Life | 1 | 2019 | 3192 | 0.060 |
Why?
| | Adolescent | 3 | 2021 | 22453 | 0.060 |
Why?
| | Risk Factors | 2 | 2019 | 10792 | 0.050 |
Why?
| | Patient Selection | 2 | 2019 | 719 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4275 | 0.050 |
Why?
| | Catheters, Indwelling | 1 | 2023 | 96 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2456 | 0.050 |
Why?
| | United States | 1 | 2020 | 15988 | 0.050 |
Why?
| | Rats | 2 | 2020 | 5614 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 139 | 0.040 |
Why?
| | Transplantation, Heterotopic | 1 | 2019 | 16 | 0.040 |
Why?
| | Rats, Inbred BN | 1 | 2019 | 55 | 0.040 |
Why?
| | Prosthesis Fitting | 1 | 2019 | 14 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2020 | 157 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2019 | 194 | 0.040 |
Why?
| | Postoperative Period | 1 | 2019 | 354 | 0.040 |
Why?
| | Bioprinting | 1 | 2019 | 34 | 0.040 |
Why?
| | Complement C4b | 1 | 2018 | 9 | 0.030 |
Why?
| | Myeloablative Agonists | 1 | 2018 | 23 | 0.030 |
Why?
| | Vidarabine | 1 | 2018 | 32 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 2019 | 127 | 0.030 |
Why?
| | Cryopreservation | 1 | 2019 | 110 | 0.030 |
Why?
| | Printing, Three-Dimensional | 1 | 2019 | 96 | 0.030 |
Why?
| | Tissue Scaffolds | 1 | 2019 | 223 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 421 | 0.030 |
Why?
| | Autografts | 1 | 2015 | 55 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 781 | 0.030 |
Why?
| | Plasma | 1 | 2016 | 225 | 0.030 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2014 | 4 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2092 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2016 | 288 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2018 | 699 | 0.030 |
Why?
| | Inguinal Canal | 1 | 2013 | 11 | 0.030 |
Why?
| | Cost Savings | 1 | 2014 | 86 | 0.030 |
Why?
| | Neoadjuvant Therapy | 1 | 2016 | 463 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2114 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2013 | 334 | 0.020 |
Why?
| | Mice | 2 | 2020 | 18365 | 0.020 |
Why?
| | Operating Rooms | 1 | 2014 | 146 | 0.020 |
Why?
| | Dogs | 1 | 2013 | 438 | 0.020 |
Why?
| | Decision Making | 1 | 2019 | 980 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2014 | 636 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 351 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4293 | 0.020 |
Why?
| | Registries | 1 | 2019 | 2385 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1385 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2014 | 456 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3335 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5997 | 0.020 |
Why?
| | Patient Readmission | 1 | 2014 | 759 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1337 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2880 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6053 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3608 | 0.010 |
Why?
|
|
Etra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|